patients with obesity who earn more than $250,000 per year are approximately 72 percent more likely to take GLP-1 drugs than those earning $50,000 or less
GLP-1 medications can be highly beneficial if youre not meeting milestones, especially after nutritional and behavioral interventions have been optimized
Similar medications in the GLP-1 class are known to cause symptoms such as: Nausea Bloating Gas Vomiting Heartburn Some research has also identified rare but more serious risks associated with GLP-1 medications, including pancreatitis, gallbladder disease, and gastrointestinal complications.[10] Because retatrutide is still being studied, researchers are continuing to evaluate its long-term safety profile
Risk of Hypoglycaemia The likelihood of low blood sugar is assessed, particularly if the patient is already on insulin or sulfonylureas
No wonder that too many oxalates can lead to urinary issues, bladder pain, and kidney stones
They manage it